Pharmacotherapy of autism spectrum disorders.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Brain & development (Tokyo. 1979)

• Publication date

  2013-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.braindev.2012.03.015PMID 22541665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glutamate mediated signaling in the pathophysiology of autism spectrum disorders.

  2012cited by this paper
• An Italian Prospective Study on Autism Treatment: The Earlier, the Better?

  2012cited by this paper
• Networking in Autism: Leveraging Genetic, Biomarker and Model System Findings in the Search for New Treatments

  2012cited by this paper
• High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network.

  2012cited by this paper
• Evaluation of the GABAergic nervous system in autistic brain: (123)I-iomazenil SPECT study.

  2012cited by this paper
• A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.

  2012cited by this paper
• Melatonin for Sleep in Children with Autism: A Controlled Trial Examining Dose, Tolerability, and Outcomes

  2012cited by this paper
• Concurrent medical conditions and health care use and needs among children with learning and behavioral developmental disabilities, National Health Interview Survey, 2006-2010.

  2012cited by this paper
• Prevalence and Correlates of Psychotropic Medication Use in Adolescents with an Autism Spectrum Disorder with and without Caregiver-Reported Attention-Deficit/Hyperactivity Disorder

  2011cited by this paper
• Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice: possible implications for the pharmacotherapy of autism spectrum disorders.

  2011cited by this paper
• Aggression in Children and Adolescents with ASD: Prevalence and Risk Factors

  2011cited by this paper
• Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey

  2011cited by this paper
• Melatonin in autism spectrum disorders: a systematic review and meta‐analysis

  2011cited by this paper
• Retrospective Review of Clozapine in the Treatment of Patients With Autism Spectrum Disorder and Severe Disruptive Behaviors

  2011cited by this paper
• Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders.

  2011cited by this paper
• Response to atomoxetine in boys with high‐functioning autism spectrum disorders and attention deficit/hyperactivity disorder

  2011cited by this paper
• Can ziconotide as a N-type voltage-sensitive calcium channel blocker open a new mode for treatment of autism? A hypothesis.

  2011cited by this paper
• Aripiprazole in the Treatment of Irritability in Pediatric Patients (Aged 6–17 Years) with Autistic Disorder: Results from a 52-Week, Open-Label Study

  2011cited by this paper
• A Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders

  2011cited by this paper
• Pre- and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress.

  2011cited by this paper
• Efficacy of Atomoxetine in Children With Severe Autistic Disorders and Symptoms of ADHD

  2011cited by this paper
• Assessment of Health-Related Quality of Life Among Primary Caregivers of Children with Autism Spectrum Disorders

  2011cited by this paper
• Genetics and Function of Neocortical GABAergic Interneurons in Neurodevelopmental Disorders

  2011cited by this paper
• Divalproex Sodium vs Placebo for the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorders

  2010cited by this paper
• Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder

  2010cited by this paper
• The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes

  2010cited by this paper
• GABAergic dysfunction mediates autism-like stereotypies and Rett syndrome phenotypes

  2010cited by this paper
• Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1

  2010cited by this paper
• Effectiveness of Medication Combined with Intensive Behavioral Intervention for Reducing Aggression in Youth with Autism Spectrum Disorder

  2010cited by this paper
• Epidemiology and Management of Insomnia in Children with Autistic Spectrum Disorders

  2010cited by this paper
• Health-Related Quality of Life in Children with Autism Spectrum Disorders: Results from the Autism Treatment Network

  2010cited by this paper
• Autism and oxytocin: New developments in translational approaches to therapeutics

  2010cited by this paper
• Possible Influence of Variant of the P-Glycoprotein Gene (MDR1/ABCB1) on Clinical Response to Guanfacine in Children with Pervasive Developmental Disorders and Hyperactivity

  2010cited by this paper
• Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

  2010cited by this paper
• Autism spectrum disorders and epilepsy: moving towards a comprehensive approach to treatment.

  2010cited by this paper
• Understanding and Determining the Etiology of Autism

  2010cited by this paper
• Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.

  2010cited by this paper
• Syndromic autism: causes and pathogenetic pathways

  2009cited by this paper
• Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

  2009cited by this paper
• A pharmacogenetic study of escitalopram in autism spectrum disorders

  2009cited by this paper
• Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder

  2009cited by this paper
• Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children.

  2009cited by this paper
• Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors.

  2009cited by this paper
• Pharmacologic treatment of impulsive aggression with antiepileptic drugs

  2009cited by this paper
• A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.

  2009cited by this paper
• Novel and emerging treatments for autism spectrum disorders: a systematic review.

  2009cited by this paper
• Positive Effects of Methylphenidate on Social Communication and Self-Regulation in Children with Pervasive Developmental Disorders and Hyperactivity

  2009cited by this paper
• Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006.

  2009cited by this paper
• How can early, intensive training help a genetic disorder?

  2009cited by this paper
• Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells.

  2009cited by this paper
• Pharmacologic treatment for the core deficits and associated symptoms of autism in children.

  2009cited by this paper
• Cognitive Effects of Risperidone in Children with Autism and Irritable Behavior

  2008cited by this paper
• Risperidone versus haloperidol in children and adolescents with AD

  2008cited by this paper
• Treatment of autism spectrum disorders: neurotransmitter signaling pathways involved in motivation and reward as therapeutic targets.

  2008cited by this paper
• Use of clonidine in children with autism spectrum disorders.

  2008cited by this paper
• Prevalence and risk factors of maladaptive behaviour in young children with Autistic Disorder.

  2008cited by this paper
• Treatment of autism spectrum disorders: neurotransmitter signaling pathways involved in motivation and reward as therapeutic targets

  2008cited by this paper
• Guanfacine in Children with Autism and/or Intellectual Disabilities

  2008cited by this paper
• Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

  2007cited by this paper
• Risperidone Improves Behavioral Symptoms in Children with Autism in a Randomized, Double-Blind, Placebo-Controlled Trial

  2007cited by this paper
• Predictors of Optimal Outcome in Toddlers Diagnosed with Autism Spectrum Disorders

  2007cited by this paper
• Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.

  2007cited by this paper
• Drug therapy for attention‐deficit/hyperactivity disorder‐like symptoms in autistic disorder

  2007cited by this paper
• Memantine as Adjunctive Therapy in Children Diagnosed With Autistic Spectrum Disorders: An Observation of Initial Clinical Response and Maintenance Tolerability

  2007cited by this paper
• Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein.

  2007cited by this paper
• Risperidone in Children With Autism: Randomized, Placebo-Controlled, Double-Blind Study

  2006cited by this paper
• Topiramate in children with autistic spectrum disorders.

  2006cited by this paper
• Neuropsychological Effects of Risperidone in Children with Pervasive Developmental Disorders: ABlinded Discontinuation Study

  2006cited by this paper
• ADouble-Blind Placebo-Controlled Pilot Study of Olanzapine in Childhood/Adolescent Pervasive Developmental Disorder

  2006cited by this paper
• Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study

  2006cited by this paper
• Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.

  2006cited by this paper
• AProspective Open Trial of Guanfacine in Children with Pervasive Developmental Disorders

  2006cited by this paper
• Open-Label Atomoxetine for Attention-Deficit/ Hyperactivity Disorder Symptoms Associated with High-Functioning Pervasive Developmental Disorders

  2006cited by this paper
• Acute and Long-Term Safety and Tolerability of Risperidone in Children with Autism

  2005cited by this paper
• Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

  2005cited by this paper
• A Placebo Controlled Crossover Trial of Liquid Fluoxetine on Repetitive Behaviors in Childhood and Adolescent Autism

  2005cited by this paper
• Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.

  2005cited by this paper
• An open-label trial of escitalopram in pervasive developmental disorders.

  2005cited by this paper
• Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.

  2005cited by this paper
• Methylphenidate for Pervasive Developmental Disorders: Safety and Efficacy of Acute Single Dose Test and Ongoing Therapy: An Open-Pilot Study

  2004cited by this paper
• A Retrospective Assessment of Topiramate in Children and Adolescents with Pervasive Developmental Disorders

  2004cited by this paper
• Pharmacologic treatment of autism.

  2004cited by this paper
• Evidence-based treatments in child and adolescent psychiatry: an inventory.

  2003cited by this paper
• Lamotrigine Therapy for Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

  2001cited by this paper
• Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

  2001cited by this paper
• Clonidine Treatment of Hyperactive and Impulsive Children with Autistic Disorder

  1992cited by this paper

• การเปลี่ยนแปลงของน้ำหนักตัวในผู้ป่วยจิตเวชที่ได้รับ risperidone ร่วมกับ topiramate

  2025cites this paper
• Effect of Yoga Intervention on Problem Behavior and Motor Coordination in Children with Autism

  2024cites this paper
• Predictors of Outcome in Autism Spectrum Disorders: A Perspective for Clinicians and Therapists

  2023cites this paper
• Parent Perceptions of the Effects of Early Intensive Behavioral Interventions for Children with Autism

  2023cites this paper
• Oxytocin protective effects on zebrafish larvae models of autism-like spectrum disorder

  2023cites this paper
• Teaching Interventions for the Development of Friendship in Students with ASD

  2022cites this paper
• Autism and associated disorders: cannabis as a potential therapy.

  2022cites this paper
• 自閉スペクトラム症 (ASD) 児の鎮静に際して必要な理解や配慮

  2021cites this paper
• Dietary Phytochemicals as Neurotherapeutics for Autism Spectrum Disorder: Plausible Mechanism and Evidence.

  2020cites this paper
• Pharmacotherapy and Bumetanide in Autism Treatment

  2020cites this paper
• Effect of prednisolone on language function in children with autistic spectrum disorder: a randomized clinical trial

  2020cites this paper
• Vitamin D Deficiency and Autism Spectrum Disorder.

  2020cites this paper
• Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and biochemical evidence

  2019cites this paper
• Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations

  2019cites this paper
• Effective Medications for Treating Individuals with Autism Spectrum Disorder

  2019cites this paper
• The effect of stimulants on irritability in autism comorbid with ADHD: a systematic review

  2019cites this paper
• NDT_A_194022 1547..1555

  2019cites this paper
• Survey interventions related to adolescents with autism spectrum disorders in puberty: a review study

  2019cites this paper
• A call for a broader citizenship : parent-led autism advocacy movement in Portugal

  2018cites this paper
• Immunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy

  2018cites this paper
• Autism spectrum disorder (ASD): A current review of assessment, risk factors and prevention

  2018cites this paper
• The endocannabinoid system and autistic behavior in the Fmr 1-KO mouse

  2018cites this paper
• Prevalence and interventions of challenging behavior in children with intellectual disabilities and/or developmental disorders or other disabilities in Iceland

  2017cites this paper
• Impact of CYP2D6 Polymorphism on Steady-State Plasma Levels of Risperidone and 9-Hydroxyrisperidone in Thai Children and Adolescents with Autism Spectrum Disorder

  2017cites this paper
• Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism

  2017cites this paper
• Shared and Disorder-Specific Neurocomputational Mechanisms of Decision-Making in Autism Spectrum Disorder and Obsessive-Compulsive Disorder

  2017cites this paper
• Drug Treatments for Core Symptoms of Autism Spectrum Disorder: Unmet Needs and Future Directions

  2017cites this paper
• Comparison of brain structure and function between adolescents with Autism Spectrum Disorder and adolescents with Obsessive-Compulsive Disorder

  2017cites this paper
• A Case of Child Anxiety Disorder with Orthostatic Dysregulation Successfully Treated with Ogikenchuto in Combination with Western Medicine

  2017cites this paper
• A Placebo-Controlled Crossover Trial of Gastrin-Releasing Peptide in Childhood Autism

  2017cites this paper
• Anti-depressant Activity of Commiphora mukul

  2016cites this paper
• Low Doses of Venlafaxine in a Young Man with ASD and Behavioral Disorders: A Case Report

  2016cites this paper
• Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder

  2016cites this paper
• Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels.

  2016influential citation
• Perioperative considerations in children with autism spectrum disorder

  2016cites this paper
• Using venlafaxine to treat behavioral disorders in patients with autism spectrum disorder.

  2016cites this paper
• Development and optimization of fluoxetine orally disintegrating tablets using Box-Behnken design

  2016cites this paper
• Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study

  2016cites this paper
• Improvement in Symptoms of Autism Spectrum Disorder in Children With the Use of Gastrin-Releasing Peptide: An Open Trial

  2016cites this paper
• The Effect of Balance Training on Disruptive Behaviors in Children with Autism Spectrum Disorders

  2016cites this paper
• Epilepsy Associated with ASD and Intellectual Disability

  2016cites this paper
• Endogenous Generation of Goals and Homeostasis

  2015cites this paper
• Aripiprazole for treating irritability in children & adolescents with autism: a systematic review

  2015cites this paper
• Consciousness, endogenous generation of goals and homeostasis

  2015cites this paper
• Low Dose Loxapine: Neuromotor Side Effects and Tolerability in Autism Spectrum Disorders

  2015cites this paper
• Development of Nutraceutical Emulsions as Risperidone Delivery Systems: Characterization and Toxicological Studies.

  2015cites this paper
• Decreased aggression and increased repetitive behavior in Pten haploinsufficient mice

  2015cites this paper
• Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder

  2015cites this paper
• Modulation of actin dynamics by Rac1 to target cognitive function

  2015cites this paper
• Serum Prolactin level in Thai Children and Adolescents with Autistic Spectrum Disorder on Long Term Risperidone Treatments

  2014cites this paper
• The relationship between sleep problems and challenging behavior among children and adolescents with autism spectrum disorder

  2014cites this paper
• Behavioral and cognitive profiling in Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder

  2014cites this paper
• Cessation of Nocturnal Enuresis after Intervention with Methylcobalamin in an 18-Year-Old Patient with Autism

  2014cites this paper
• Developing zebrafish models of autism spectrum disorder (ASD).

  2014cites this paper
• The Process of Diagnosis Delivery of Autism Spectrum Disorders

  2014cites this paper
• Recommendations for early diagnosis and intervention in autism spectrum disorders: an Italian-Israeli consensus conference.

  2014cites this paper
• Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests.

  2014cites this paper
• Are caesarean sections, induced labor and oxytocin regulation linked to Autism Spectrum Disorders?

  2014cites this paper
• Clinical Approach in Autism: Management and Treatment

  2013influential citation
• The methodology and efficacy of cognitive behavioural therapy, occupational therapy and speech/language therapy: a critical review

  2013cites this paper
• Autism as the Early Closure of a Neuroplastic Critical Period Normally Seen in Adolescence.

  2013cites this paper
• Autism Spectrum Disorders in Mexico

  2013cites this paper
• The Medical Treatment of Autism Disorders

  2013cites this paper
• Pharmacological fMRI on the effects of Fluoxetine on functions of working memory, impulsiveness and cognitive flexibility in boys with Attention Deficit Hyperactivity Disorder and boys with Autism Spectrum Disorder

  2013cites this paper
• Clinical and therapeutic implications of psychiatric comorbidity in high functioning autism/Asperger syndrome: An Italian study

  2013cites this paper
• Stem Cell Research: An Opportunity for Autism Spectrum Disorders Treatment

  2012cites this paper
• Changing Concepts and Findings on Autism

  2012cites this paper
• Autism Spectrum Disorders and Intellectual Disability

  2011cites this paper
• Autism as the Early Closure of a Neuroplastic Critical Period Autism as the Early Closure of a Neuroplastic Critical Period Normally Seen in Adolescence Normally Seen in Adolescence

  year unknowncites this paper